Conditions + Treatments

Hemangiopericytoma in Children

LIke ThisLIke ThisLIke ThisLIke ThisLIke This

Contact Dana-Farber/ Boston Children's

Overview

Hemangiopericytoma is a rare tumor that grows in the body’s soft tissue, which includes fat, muscles, tendons, nerves, blood vessels and other fibrous tissue.

  • In a baby, this condition is called "infantile myofibromatosis," and the tumors typically go away on their own.
  • In adolescence, the tumor can be benign or malignant; it’s often found in bones, but can spread to the teenager’s lungs.
  • In the United States, about 900 children and adolescents are diagnosed with soft-tissue tumors each year.

The latest research from Dana-Farber/Children's Hospital Cancer Center

Dana-Farber/Children's Hospital Cancer Center researchers are conducting numerous research studies that will help clinicians better understand and treat soft-tissue sarcomas. Innovative types of treatment currently being studied include:

  • Angiogenesis inhibitors — substances that may be able to prevent the growth of tumors by blocking the formation of new blood vessels that feed the tumors.
  • Biological therapies — a wide range of substances that may be able to involve the body's own immune system to fight cancer or lessen harmful side effects of some treatments.
Boston Children’s is so much more than a hospital—it’s a community of researchers, clinicians, administrators, support staff, innovators, teachers, patients and families, all working together to make the impossible possible. ”
- Sandra L. Fenwick, President and CEO

Boston Children's Hospital
300 Longwood Avenue, Boston, MA 02115
For Patients: 617-355-6000
For Referring Providers: 844-BCH-PEDS | 844-224-7337

Close